HMGB1 and vitiligo: Increasing numbers of studies have identified HMGB1 as an activity biomarker in various autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus and vitiligo (6, 7).